Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Sep 13, 2026

    2026 Interim Results Online Conference

  2. May 19, 2026

    Preclinical Data Analysis of Obesity Pipeline LET003

  3. Apr 23, 2026

    2025 Annual Results Online Conference

  4. Dec 17, 2025

    Latest Business Update of Harbour BioMed

  5. Sep 23, 2025

    2025 Interim Results Online Conference